Peptide glossary · Compounding, controls and sport
503A and 503B compounding
Checked against U.S. Food and Drug AdministrationPublished by PepVault
503A and 503B are the two parts of US drug law on compounding: 503A covers state-licensed pharmacies, 503B FDA-registered outsourcing facilities.
What it means
Outsourcing facilities are inspected by the FDA and must follow its manufacturing quality rules (CGMP); pharmacies under 503A are overseen mainly by state boards of pharmacy and don’t have to. Each section limits which raw ingredients may be used. This is the US meaning.
This page gives the term’s meaning in the United States; other countries’ rules differ.
Why it matters when you track peptides
The legal-status pages say, compound by compound, whether either kind of pharmacy may make it, the question behind most compounded peptide offers.

Where you meet it
Checked against
U.S. Food and Drug Administration, “Compounding and the FDA: Questions and Answers”